Bio-Techne

377 articles about Bio-Techne

• BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

  2/1/2022

  Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2021 .

• BIO-TECHNE ANNOUNCES COMMERCIAL RELEASE OF HIGH SENSITIVITY FLUORESCENT DETECTION STELLAR NIR / IR™ MODULES FOR JESS AUTOMATED WESTERN BLOTTING SYSTEM

  1/18/2022

  Stellar modules set a new standard for western blotting fluorescence detection sensitivity.

• BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS

  1/17/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, February 1, 2022 , at 8:00 a.m. CST to review second quarter fiscal 2022 financial results.

• Bio-Techne Announces Updated Presentation Time At The J.P. Morgan Healthcare Conference

  1/7/2022

  Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:15 a.m. EST.

• Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

  1/5/2022

  Bio-Techne and Akoya Biosciences, Inc. announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.

• Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

  1/5/2022

  Akoya Biosciences, Inc., and Bio-Techne today announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.

• BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE

  1/3/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 , at 4:30 p.m. EST.

• BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES

  12/27/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Brenda Everson as Senior Vice President, Human Resources effective January 10, 2022 .

• BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT

  12/21/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced William A. Geist has been appointed President, Protein Sciences Segment, effective January 3 , 2022. 

• BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT

  12/14/2021

  Bio-Techne Corporation today announced it has entered into an option agreement with Wilson Wolf Corporation.  

• Bio-Techne Announces Publication of Lateral Flow Technology Proof-of-Concept Data

  12/8/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of an important manuscript in the journal Scientific Reports, a Nature Research journal, showing proof-of-concept of its proprietary lateral flow technology.

• Bio-Techne To Present At Upcoming Investor Conferences

  11/22/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at two upcoming investor conferences.

• Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference

  11/9/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present at the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021 at 10:00 a.m. EDT .

• Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

  11/8/2021

  Bio-Techne Corporation announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene.

• Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference

  11/4/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present virtually at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, November 9, 2021 at 11:20 a.m. EST

• Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility

  11/3/2021

  Bio-Techne Corporation announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP manufacturing facility.

• Bio-Techne Releases First Quarter Fiscal 2022 Results

  11/2/2021

  Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2021.

• Bio-Techne Declares Dividend - Nov 02, 2021

  11/2/2021

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2021.

• Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

  10/13/2021

  Bio-Techne Corporation today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in the journal Prostate Cancer and Prostatic Diseases , entitled Predicting high-grade prostate cancer at initial biopsy

• Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results

  10/11/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021 , at 8:00 a.m. CDT to review first quarter 2022 financial results.